🚨 LILLY PLANS PHASE 3 TRIALS ON OBESITY DRUG COMBO Lilly said it plans to start Phase 3 trials at the end of the year. The combo adds its amylin drug eloralintide to tirzepatide. Source: CNBC #EliLilly #obesityregimen #midstagetrial
